X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (463) 463
Publication (93) 93
Newspaper Article (89) 89
Paper (79) 79
Book / eBook (28) 28
Patent (12) 12
Book Chapter (1) 1
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (111) 111
experiment (85) 85
experimental results (83) 83
humans (82) 82
particle physics (81) 81
high energy physics - experiment (80) 80
physics - high energy physics - experiment (80) 80
cern lhc coll (78) 78
hep (77) 77
physics (77) 77
p p: colliding beams (72) 72
p p: scattering (72) 72
male (67) 67
female (61) 61
ex (58) 58
middle aged (45) 45
statistical (43) 43
aged (38) 38
high energy physics (37) 37
7000 gev-cms8000 gev-cms (34) 34
adult (34) 34
animals (32) 32
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (31) 31
research (30) 30
analysis (27) 27
hadron-hadron scattering (26) 26
lhc-b (25) 25
lhcb (23) 23
colliding beams [p p] (22) 22
scattering [p p] (22) 22
cp: violation (21) 21
mass spectrum: (21) 21
oncology (21) 21
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (20) 20
nuclear experiment (20) 20
particles and fields (19) 19
diagnosis (18) 18
to be checked by faculty (18) 18
infectious diseases (17) 17
medicine (17) 17
particle physics - experiment (17) 17
patients (17) 17
7000 gev-cms8000 gev-cms13000 gev-cms (16) 16
care and treatment (16) 16
hep-ex (16) 16
management (16) 16
mortality (16) 16
risk factors (16) 16
asymmetry: cp (15) 15
b physics (15) 15
cancer (15) 15
elementary particles and fields (15) 15
muon: pair production (15) 15
rats (15) 15
young adult (15) 15
abridged index medicus (14) 14
library approved (14) 14
microbiology (14) 14
branching ratio: ratio: measured (13) 13
epidemiology (13) 13
flavor physics (13) 13
health aspects (13) 13
medicine, general & internal (13) 13
multidisciplinary sciences (13) 13
research article (13) 13
treatment outcome (13) 13
13000 gev-cms (12) 12
cardiac & cardiovascular systems (12) 12
clinical trials (12) 12
nuclear and particle physics. atomic energy. radioactivity (12) 12
oxidative stress (12) 12
pharmacology & pharmacy (12) 12
phenomenology (12) 12
physics, multidisciplinary (12) 12
physics, particles & fields (12) 12
decay (11) 11
medicine, research & experimental (11) 11
prevalence (11) 11
prevention (11) 11
rapidity dependence (11) 11
rats, wistar (11) 11
science (11) 11
spain (11) 11
studies (11) 11
adolescent (10) 10
aged, 80 and over (10) 10
cp violation (10) 10
expression (10) 10
hypertension (10) 10
physiological aspects (10) 10
radiation therapy (10) 10
therapy (10) 10
tool (10) 10
b0: hadronic decay (9) 9
clinical neurology (9) 9
dose-response relationship, drug (9) 9
double-blind method (9) 9
endothelial dysfunction (9) 9
endothelium, vascular - drug effects (9) 9
glioblastoma (9) 9
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (17) 17
UTL at Downsview - May be requested (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Earth Sciences (Noranda) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Online Resources - Online (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University CRRS - Library use only (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (404) 404
Spanish (169) 169
Portuguese (29) 29
French (4) 4
Latin (4) 4
German (2) 2
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Weller, Michael and Butowski, Nicholas and Tran, David D and Recht, Lawrence and Recht, Lawrence D and Lim, Michael and Hirte, Hal and Ashby, Lynn and Mechtler, Laszlo and Goldlust, Samuel and Goldlust, Samuel A and Iwamoto, Fabio and Drappatz, Jan and O'Rourke, James and O'Rourke, Donald M and Wong, Mark and Hamilton, Mark G and Hamilton, Mark and Finocchiaro, Gaetano and Perry, James and Wick, Wolfgang and Green, Jennifer and He, Yi and Turner, Christopher D and Yellin, Michael J and Keler, Tibor and Davis, Thomas A and Stupp, Roger and Sampson, John H and Campian, Jian and Becker, Kevin and Barnett, Gene and Nicholas, Garth and Desjardins, Annick and Benkers, Tara and Wagle, Naveed and Groves, Morris and Kesari, Santosh and Horvath, Zsolt and Merrell, Ryan and Curry, Richard and Schuster, David and Mrugala, Maciej and Jensen, Randy and Trusheim, John and Lesser, Glenn and Belanger, Karl and Sloan, Andrew and Purow, Benjamin and Fink, Karen and Raizer, Jeffrey and Schulder, Michael and Nair, Suresh and Peak, Scott and Brandes, Alba and Mohile, Nimish and Landolfi, Joseph and Olson, Jon and Jennens, Ross and DeSouza, Paul and Robinson, Bridget and Crittenden, Marka and Shih, Kent and Flowers, Alexandra and Ong, Shirley and Connelly, Jennifer and Hadjipanayis, Costas and Giglio, Pierre and Mott, Frank and Mathieu, David and Lessard, Nathalie and Sepulveda, Sanchez Juan and Lövey, József and Wheeler, Helen and Inglis, Po-Ling and Hardie, Claire and Bota, Daniela and Lesniak, Maciej and Portnow, Jana and Frankel, Bruce and Junck, Larry and Thompson, Reid and Berk, Lawrence and McGhie, John and Macdonald, David and Saran, Frank and Soffietti, Riccardo and Blumenthal, Deborah and André de, Sá Barreto Costa Marcos and Nowak, Anna and Singhal, Nimit and Hottinger, Andreas and Schmid, Andrea and Srkalovic, Gordan and Baskin, David and Fadul, Camilo and Nabors, Louis and LaRocca, Renato and Villano, John and Paleologos, Nina and ... and ACT IV Trial Investigators and ACT IV trial investigators
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1373 - 1385
Rindopepimut (also known as CDX-110), a vaccine targeting the deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet... 
GLIOMAS | ONCOLOGY | RECURSIVE PARTITIONING ANALYSIS | GROWTH-FACTOR | RADIOTHERAPY | CANCER | PEPTIDE | ADJUVANT TEMOZOLOMIDE | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | ErbB Receptors - genetics | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Dose-Response Relationship, Drug | Young Adult | Glioblastoma - genetics | Time Factors | Dacarbazine - analogs & derivatives | Adult | Female | Vaccines, Subunit - adverse effects | Brain Neoplasms - mortality | Dacarbazine - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Cancer Vaccines - adverse effects | Treatment Outcome | Brain Neoplasms - drug therapy | Disease-Free Survival | Internationality | Vaccines, Subunit - administration & dosage | Glioblastoma - pathology | Survival Analysis | Aged | Temozolomide | Glioblastoma - drug therapy | Glioblastoma - mortality | Antimitotic agents | Clinical trials | Care and treatment | Product development | Antineoplastic agents | Glioblastoma multiforme | Analysis
Journal Article
Neuro-Oncology, ISSN 1522-8517, 08/2016, Volume 18, Issue 8, pp. 1146 - 1156
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e13517 - e13517
Journal Article
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 05/2017, Volume 18, Issue 5, p. 995
Galunisertib, a Transforming growth factor-beta RI (TGF-beta RI) kinase inhibitor, blocks TGF-beta-mediated tumor growth in glioblastoma. In a three-arm study... 
Biomarkers | pSMAD2 | TGF-β | Galunisertib monohydrate (LY2157299) | CDK4/CDK6 | SURVIVAL | IMMUNE CELLS | biomarkers | BIOCHEMISTRY & MOLECULAR BIOLOGY | PHASE-II | CANCER | CHEMISTRY, MULTIDISCIPLINARY | TUMOR-INFILTRATING LYMPHOCYTES | TGF-beta | galunisertib monohydrate (LY2157299) | RADIOTHERAPY | Pyrazoles - therapeutic use | Humans | Lomustine - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Quinolines - administration & dosage | Neoplasm Recurrence, Local - pathology | CD4-CD8 Ratio | Forkhead Transcription Factors - metabolism | Biomarkers, Tumor - metabolism | Adult | Female | Lomustine - therapeutic use | Neoplasm Recurrence, Local - blood | Cytokines - blood | Pyrazoles - adverse effects | Glioblastoma - blood | Smad2 Protein - metabolism | Antineoplastic Combined Chemotherapy Protocols | Biomarkers, Tumor - blood | Pyrazoles - administration & dosage | Forkhead Transcription Factors - blood | Glioblastoma - pathology | Survival Analysis | Isocitrate Dehydrogenase - metabolism | Quinolines - therapeutic use | Glioblastoma - drug therapy | Lomustine - administration & dosage | Quinolines - adverse effects | Therapy | CD8 antigen | Glioblastoma | Transforming growth factor-a | Lymphocytes T | Dehydrogenase | Kinases | Macrophages | CCL22 protein | Alterations | Macrophage-derived chemokine | Histopathology | Lymphocytes | Foxp3 protein | Isocitrate dehydrogenase | Dosing | Leukocytes (eosinophilic) | Glial fibrillary acidic protein | Markers | Pharmacology | CD3 antigen | Assessments | Patients | Survival | CD4 antigen | Pathology | Inhibitors | Chemokines | Cytoplasm | Plasmas (physics) | Eosinophils | Tumors
Journal Article
Proceedings of the National Academy of Sciences of the United States, ISSN 0027-8424, 06/2016, Volume 113, Issue 23, p. E3231
Large-conductance [Ca.sup.2+]- and voltage-activated [K.sup.+] (BK) channels are involved in a large variety of physiological processes. Regulatory... 
Electrophysiology | Calcium channels | Potassium channels | Observations | Health aspects
Journal Article
Proceedings of the National Academy of Sciences, USA, ISSN 0027-8424, 06/2016, Volume 113, Issue 23, pp. E3231 - E3231
Large-conductance Ca super( 2+)- and voltage-activated K super( +) (BK) channels are involved in a large variety of physiological processes. Regulatory beta... 
Journal Article
Journal Article
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, ISSN 1942-0900, 08/2019, Volume 2019, pp. 9719730 - 12
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.